Skip to main content
Log in

Interceptor potential of C60 fullerene aqueous solution: a comparative analysis using the example of the antitumor antibiotic mitoxantrone

  • Original Article
  • Published:
European Biophysics Journal Aims and scope Submit manuscript

Abstract

We performed a qualitative and quantitative analysis of intermolecular interactions in aqueous solution between the antitumor antibiotic mitoxantrone and C60 fullerene in comparison with interactions between the antibiotic and well-known aromatic molecules such as caffeine and flavin mononucleotide, commonly referred to as interceptor molecules. For these purposes, we obtained equilibrium hetero-association constants of these interactions using a UV/Vis titration experiment. Special attention was paid to the interaction of C60 fullerene with mitoxantrone, which has been quantified for the first time. Based on the theory of interceptor-protector action and using a set of measured equilibrium constants we managed to estimate the relative biological effect of these mixtures in a model living system, taking human buccal epithelium cells as an example. We demonstrated that C60 fullerene is able to restore the functional activity of the buccal epithelium cell nucleus after exposure to mitoxantrone, which makes it possible to use C60 fullerene as regulator of medico-biological activity of the antibiotic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

Download references

Acknowledgements

This work was financially supported by the Ministry of Science and Higher Education of the Russian Federation (project no. FEFM-2020-0003). The authors thank the Resource center ‘Molecular structure of matter’ of Sevastopol State University for access to equipment.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anatoly S. Buchelnikov.

Ethics declarations

Conflict of interest

The authors declare no conflict of interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 75 KB)

Appendix: Calculation of the A D factor

Appendix: Calculation of the A D factor

The AD factor is calculated according to Eq. (7):

$$A_{{\text{D}}} = \frac{{\theta_{X}^{\left( 0 \right)} - \theta_{X} }}{{\theta_{X}^{\left( 0 \right)} }},$$
(8)

where θX and \(\theta_{X}^{\left( 0 \right)}\) are the mole fractions of NOV-DNA complexes in the presence and in the absence of interceptor molecules, respectively. Therefore, the calculation of the AD factor is reduced to calculation of these mole fractions.

Consider a three-component system containing mitoxantrone molecules (X), interceptor molecules, i.e., caffeine, flavin mononucleotide or C60 fullerene (Y), and DNA (N). Let us introduce the total concentrations of these species as x0, y0 and N0, respectively. Note, the DNA concentration is measured in moles of base pairs per liter. To describe non-cooperative DNA binding we use standard approach taken from Ref. (Evstigneev et al. 2008).

For such a system, the mass balance equations are written in general form as follows (Evstigneev et al. 2019):

$$\left\{ \begin{gathered} x_{0} = x_{{{\text{het}}}} + K_{XN} x_{1} N_{1} \hfill \\ y_{0} = y_{{{\text{het}}}} + K_{YN} y_{1} N_{1} \hfill \\ N_{0} = N_{1} + K_{XN} x_{1} N_{1} + K_{YN} y_{1} N_{1} \hfill \\ \end{gathered} \right.,$$
(9)

where xhet, yhet are the overall concentrations of X- and Y-containing hetero-aggregates including monomers, respectively; x1, y1 are the monomer concentrations of X and Y compounds; N1 is the concentration of free DNA; KXN, KYN are the equilibrium constants of X and Y monomers bound to DNA. Equation (9) can be easily rewritten to

$$\left\{ \begin{gathered} x_{0} = x_{{{\text{het}}}} + \frac{{K_{XN} x_{1} }}{{1 + K_{XN} x_{1} + K_{YN} y_{1} }}N_{0} \hfill \\ y_{0} = y_{{{\text{het}}}} + \frac{{K_{YN} y_{1} }}{{1 + K_{XN} x_{1} + K_{YN} y_{1} }}N_{0} \hfill \\ \end{gathered} \right.,$$
(10)

The θX quantity is given as

$$\theta_{X} = \frac{{K_{XN} x_{1} }}{{1 + K_{XN} x_{1} + K_{YN} y_{1} }}.$$
(11)

Now, we can easily reduce Eq. (10) to obtain the equation for calculation of the \(\theta_{X}^{\left( 0 \right)}\) quantity by mental exclusion of interceptor molecules from the system. This is expressed in zeroing of all the terms in Eq. (10) related to Y molecules. Thus, one obtains the equation

$$x_{0} = \left. {x_{{{\text{het}}}} } \right|_{{y_{1} = 0}} + \frac{{K_{XN} x_{1} }}{{1 + K_{XN} x_{1} }}N_{0} ,$$
(12)

to be solved for \(\theta_{X}^{\left( 0 \right)}\) as \(\frac{{K_{XN} x_{1} }}{{1 + K_{XN} x_{1} }}\).

The explicit form of the xhet and yhet quantities depends on particular model of hetero-association which, in turn, is selected upon the type of interacting molecules. We study the interceptor molecules of two different types, viz. aromatic ligands (caffeine and flavin mononucleotide) containing planar chromophore which makes molecules be able to form stacking complexes with similar compounds and DNA, and C60 fullerene possessing specific affinity to aromatic ligands which mitoxantrone belongs to. Moreover, C60 fullerene is assumed not to bind with DNA (see “Description of biological data within the framework of the IPA theory” of the paper). Therefore, we should consider two cases of competitive DNA binding.

Case 1: caffeine and flavin mononucleotide are the interceptor molecules

To describe the aggregation of aromatic compounds, such as caffeine and flavin mononucleotide, with mitoxantrone we use 1:2 hetero-association model (Thordarson 2011). The corresponding mass balance equations are given in Eq. (2) in “Hetero-association model for the antibiotic and aromatic interceptors, CAF/FMN” of the paper. They exactly equal to the xhet and yhet quantities in Eq. (10). Thus, one obtains:

$$\left\{ \begin{gathered} x_{0} = x_{1} + K_{h} x_{1} y_{1} + \frac{{K_{XN} x_{1} }}{{1 + K_{XN} x_{1} + K_{YN} y_{1} }}N_{0} \hfill \\ y_{0} = y_{1} + 2K_{Y} y_{1}^{2} + K_{h} x_{1} y_{1} + \frac{{K_{YN} y_{1} }}{{1 + K_{XN} x_{1} + K_{YN} y_{1} }}N_{0} \hfill \\ \end{gathered} \right..$$
(13)

Putting y1 = 0 in Eq. (13) yields:

$$x_{0} = x_{1} + \frac{{K_{XN} x_{1} }}{{1 + K_{XN} x_{1} }}N_{0} ,$$
(14)

which has exact solution in the following form:

$$x_{1} = \frac{{ - 1 - K_{XN} \left( {N_{0} - x_{0} } \right) + \sqrt {\left( {1 + K_{XN} \left( {N_{0} - x_{0} } \right)} \right)^{2} + 4K_{XN} x_{0} } }}{{2K_{XN} }}.$$
(15)

Hence, we readily obtain the expression for the \(\theta_{X}^{\left( 0 \right)}\) quantity:

$$\theta_{X}^{\left( 0 \right)} = \frac{{ - 1 - K_{XN} \left( {N_{0} - x_{0} } \right) + \sqrt {\left( {1 + K_{XN} \left( {N_{0} - x_{0} } \right)} \right)^{2} + 4K_{XN} x_{0} } }}{{1 - K_{XN} \left( {N_{0} - x_{0} } \right) + \sqrt {\left( {1 + K_{XN} \left( {N_{0} - x_{0} } \right)} \right)^{2} + 4K_{XN} x_{0} } }}.$$
(16)

Numerical solution of Eq. (13) allows one to obtain the θX quantity to be further substituted into Eq. (8) along with Eq. (16) to calculate AD factor for NOV-CAF-DNA and NOV-FMN-DNA systems.

Case 2: C60 fullerene is the interceptor molecule

To describe the aggregation in NOV-C60 system we use up-scaled model (Mosunov et al. 2019). Similarly to the above, the xhet and yhet quantities are given as the first and the second equation, respectively, in Eq. (4) in “Complexation model for the antibiotic and C60 fullerene” of the paper.

The exclusion of protector mechanism of action, i.e. DNA binding of C60 fullerene, results in KYN = 0. Hence, the set of equations to calculate θX in the form of \(\frac{{K_{XN} x_{1} }}{{1 + K_{XN} x_{1} }}\) is written as:

$$\left\{ \begin{gathered} x_{0} = x_{1} + BK_{{{\text{h1}}}} x_{1} C_{{{\text{R1}}}} + C_{{\text{M}}} \frac{{HK_{{{\text{h2}}}} x_{1} }}{{1 - K_{{{\text{h2}}}} x_{1} }} + \frac{{K_{XN} x_{1} }}{{1 + K_{XN} x_{1} }}N_{0} \hfill \\ C_{0} = BC_{{{\text{R1}}}} + BK_{{{\text{h1}}}} x_{1} C_{{{\text{R1}}}} + C_{{\text{M}}} \frac{{1 - \left( {1 - B} \right)BK_{{\text{F}}} C_{{{\text{R1}}}} }}{{1 - BK_{{\text{F}}} C_{{{\text{R1}}}} }} \hfill \\ \end{gathered} \right.,$$
(17)

where CD0, CD1 were substituted for x0, x1, respectively.

Setting CR1 and CM to zero in Eq. (17) yields the equation similar to Eq. (14). Thus, one can numerically solve Eqs. (17), (16) to obtain the θX and \(\theta_{X}^{\left( 0 \right)}\) quantities, respectively, and further substitute them into Eq. (8) to calculate AD factor for NOV-C60-DNA system.

Table

Table 3 The values of the equilibrium parameters of complexation needed to calculate the AD factor

3 summarizes all the parameters needed to calculate the AD factor for both cases.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salo, V.A., Buchelnikov, A.S. & Evstigneev, M.P. Interceptor potential of C60 fullerene aqueous solution: a comparative analysis using the example of the antitumor antibiotic mitoxantrone. Eur Biophys J 51, 297–307 (2022). https://doi.org/10.1007/s00249-022-01597-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00249-022-01597-x

Keywords

Navigation